Vital Science
Vital Science
✓

H-Guard: Improving Physical and Mental Health

00:28:06
Podcasts
RSS
Link

SELLEST OSAST

For the 850 million people around the world suffering from chronic kidney disease, the grind of dialysis treatment can wear them down in more ways than one.   

 

Dr. Andy Herbert, co-founder of Invizius, is out to change that. This five-year-old company started from humble beginnings and is currently developing H-Guard® Priming Solution, which increases the effectiveness of dialysis while negating, or eliminating, its potentially dangerous side effects. It will be used in an upcoming first-in-human clinical trial and has the potential to improve patients’ quality of life – both physically and mentally.  

 

Join Dr. Herbert as we discuss the origins of Invizius, how H-Guard works, why dialysis can take a toll on mental health, and how working with a strategic partner has helped Invizius progress this treatment.

Show Notes  

 
Invizius 

Charles River's Nonclinical Support Helps Invizius Secure MHRA Approval for First-in-Human Trial of H-Guard® Hemodialysis Solution 

Renal Disorders | Charles River 

Preclinical CRO Services for Safety Assessment 

Inflammation | Charles River

Elu teadused
Teadus
Tehnoloogia
Inglise
Ameerika Ühendriigid
Kasutage selle jao toomiseksJSON-s funktsiooniAPI

SELLES OSAS

Muuda neid silte

TRANSKRIBEERI 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

OTSI VARASEMAID OSASID

Otsi kanali Vital Science viimaseid osasid.
Manusta see otsinguriba oma veebisaidile

MUUD EPISOOD SELLES PODCASTIS

Moving FAST to Treat Angelman Syndrome

Moving FAST to Treat Angelman Syndrome

The effects of Angelman Syndrome (AS) on young children are debilitating. From an early age, they face an uphill battle with this neurogenetic disease’s unrelenting symptoms, including seizures, cognitive impairments, and loss of motor function.  It can also be tough on caretakers – just ask Dr. A…
00:30:42
JAGA
SALVESTA
Strength in Numbers

Strength in Numbers

Imagine a world where your child has a rare disease that’s so rare, it doesn’t have a name and only a handful of people around the world have a similar condition. It can leave you feeling helpless and alone knowing the odds are stacked against you.    This is the situation Bo Bigelow experienced wi…
00:54:06
JAGA
SALVESTA
SCA3: A Family Affair

SCA3: A Family Affair

Spinocerebellar ataxia type 3 (SCA3) is a neuromuscular disease affecting just 50,000 people in the United States, including three generations of the Klassen family.     Greg Klassen, his father, and his son have all been diagnosed with this rare condition that impacts the central nervous system, a…
00:23:49
JAGA
SALVESTA
Modernizing Drug Development

Modernizing Drug Development

For decades, researchers have utilized animal models to help predict the effects of a drug compound in humans.     With recent advances in technology and the passage of the FDA Modernization Act 2.0, researchers are increasingly looking at new methods to refine, reduce, and replace in vivo testing …
00:25:58
JAGA
SALVESTA
Emily Whitehead: Pioneer and Hero

Emily Whitehead: Pioneer and Hero

18-year-old Emily Whitehead aspires to be a writer, but nothing could have prepared her for the plot twist that struck her as a child.     In the space of just 24 hours, five-year-old Emily suffered from various symptoms that culminated in a diagnosis of acute lymphoblastic leukemia (ALL). After al…
00:33:29
JAGA
SALVESTA
Vastutamatussäte: Sellele lehele manustatud taskuhäälingusaade ja kunstiteosed pärinevad Charles River-lt, mis on selle omaniku omand ja ei ole seotud ettevõttega Listen Notes, Inc.
PROMOTED
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
Bid on eBay

SOOVITUSED
Kasuta API-t selle osa laadimiseks